Cargando…

Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy

BACKGROUND: IgA nephropathy(IgAN)) is the common pathological type of glomerular diseases. The role of gut microbiota in mediating “gut-IgA nephropathy” has not received sufficient attention in the previous studies. The purpose of this study was to investigate the changes of fecal short-chain fatty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Lingxiong, Luo, Qun, Cai, Kedan, Wang, Kaiyue, Xu, Binbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173972/ https://www.ncbi.nlm.nih.gov/pubmed/34082732 http://dx.doi.org/10.1186/s12882-021-02414-x

Ejemplares similares

The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
por: Zhong, Chenyu, et al.
Publicado: (2021)

Full age spectrum equation versus CKD-EPI and MDRD equations to estimate glomerular filtration rate in adults with obstructive nephropathy
por: Cai, Kedan, et al.
Publicado: (2019)

Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
por: YAMAMURA, Ryodai, et al.
Publicado: (2019)

Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
por: Lauriero, Gabriella, et al.
Publicado: (2021)

Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports
por: Zhao, Jin, et al.
Publicado: (2021)

ISN Forefronts Symposium 2015: IgA Nephropathy, the Gut Microbiota, and Gut−Kidney Crosstalk
por: Han, Lijuan, et al.
Publicado: (2016)

Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study
por: Hu, Xiaofang, et al.
Publicado: (2020)

Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease
por: Hu, Xueli, et al.
Publicado: (2022)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
por: Li, Guanhong, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

The Association Between Fecal Short-Chain Fatty Acids, Gut Microbiota, and Visceral Fat in Monozygotic Twin Pairs
por: Yin, Xing-Qi, et al.
Publicado: (2022)

Microbiota metabolite short chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43
por: Wu, Wei, et al.
Publicado: (2016)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
por: Monteiro, Renato C., et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy—Based on Mendelian Randomization and Clinical Validation
por: Wang, Fang, et al.
Publicado: (2023)

Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study
por: Ren, Feihong, et al.
Publicado: (2023)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Fecal Capsule as a Therapeutic Strategy in IgA Nephropathy: A Brief Report
por: Zhi, Wenqiang, et al.
Publicado: (2022)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances
por: Lou, Xiran, et al.
Publicado: (2023)

Omega-3 Polyunsaturated Fatty Acids for the Treatment of IgA Nephropathy
por: Hirahashi, Junichi
Publicado: (2017)

Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients
por: Sun, Qing Hua, et al.
Publicado: (2021)

Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: The METS-Microbiome Study
por: Gilbert, Jack, et al.
Publicado: (2023)

Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: The METS-Microbiome Study
por: Ecklu-Mensah, Gertrude, et al.
Publicado: (2023)

Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study
por: Ecklu-Mensah, Gertrude, et al.
Publicado: (2023)

Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1
por: Tang, Yuyan, et al.
Publicado: (2022)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy
por: Liang, Xiaolin, et al.
Publicado: (2022)

Insoluble Fiber in Barley Leaf Attenuates Hyperuricemic Nephropathy by Modulating Gut Microbiota and Short-Chain Fatty Acids
por: Li, Yongmei, et al.
Publicado: (2022)

Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy
por: Ravipati, Prasanth, et al.
Publicado: (2022)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p91sundhhltaqqhilirlp96j7o